Impact evaluation of European strategy on Spanish National Plan on Drugs and the role of civil society
DOI:
https://doi.org/10.20882/adicciones.1726Keywords:
Civil society, qualitative research, Plan de Acción Nacional de Drogas, impact evaluation.Abstract
The European Drug Strategy (2013-2020) addressed the issues of illicit drugs, new psychoactive substances, the legal sale of alcohol, tobacco and medicines with addictive potential, and behavioural addictions, promoting coordination between EU member states and within individual national action plans (European Monitoring Centre for Drug Dependency and Addiction, 2017). Coordination is a way of ensuring that actions and policies are as reasonable and efficient as possible (O’Gorman, Quigley, Zobel & Moore, 2014); it provides an action framework to prevent potential duplication; it leverages and pools efforts; it reduces people’s care and treatment timelines (EMCDDA, 2017); it saves and maximises the use of resources (financial and human) and promotes significant levels of involvement for each of the organisations forming part of the Spanish National Plan on Drugs (PNSD, 2020). The strategic objectives of the national strategy include encouraging and promoting meaningful participation and engagement of civil society (scientific and professional associations, NGOs, social partners, neighbourhood associations and others), for the purpose of which these organisations were invited to join the Spanish Council on Drug and Other Addictions.References
Belackova, V., Ritter, A., Shanahan, M. y Hughes, C. E. (2016). Assessing the concordance between illicit drug laws on the books and drug law enforcement: Comparison of three states on the continuum from “decriminalised” to “punitive”. The International Journal of Drug Policy, 41, 148-157. doi:10.1016/j.drugpo.2016.12.013.
Creswell, J.W. y Creswell, J.D. (2017). Research design: Qualitative, quantitative, and mixed methods approaches. SAGE Publications.
Ernesto, S. P. (2017). UNGASS 2016 y el nuevo paradigma sobre el problema mundial de las drogas. Desafíos, 29, 353-367. Recuperado de https://revistas.urosario.edu.co/index.php/desafios/article/view/5302.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2017). Respuestas sanitarias y sociales a los problemas relacionados con las drogas: Una guía europea. Luxemburgo: Oficina de publicaciones de la Unión Europea. Recuperado de https://www.emcdda.europa.eu/publications/edr/trends-developments/2020_en.
Flick, U. (2018). An introduction to qualitative research. SAGE Publications.
Korf, D. J., O’Gorman, A. y Werse, B. (2017). The European society for social drug research: A reflection on research trends over time. Drugs: Education, Prevention & Policy, 24, 321-323. doi:10.1080/09687637.2017.1346061.
O’Gorman, A., Quigley, E., Zobel, F. y Moore, K. (2014). Peer, professional, and public: An analysis of the drugs policy advocacy community in Europe. The International Journal of Drug Policy, 25, 1001-1008. doi:10.1016/j.drugpo.2014.04.020.
Plan Nacional Sobre Drogas (2020). National strategy on addictions 2017-2024. Madrid, Government Delegation for the National Plan on Drugs. NIPO: 731-19-004-2. Recuperado de https://pnsd.sanidad.gob.es/pnsd/estrategiaNacional/docs/ESTRATEGIA_ADICCIONES_2017-2024_en_ingles.pdf.
Tiburcio, N. y Kressel, D. (2011). An enhanced understanding of therapeutic communities worldwide. Revista Adicción y Ciencia, 1. Recuperado de http://adiccionyciencia.info/wp-content/uploads/2015/10/tiburcio_1_4.pdf.
Tong, A., Sainsbury, P. y Craig, J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19, 349–357. doi:10.1093/intqhc/mzm042.
